Longevity Health receives Nasdaq delisting notice for bid-price deficiency; hearing April 15

Longevity Health Holdings, Inc.

Failed to regain $1.00 minimum bid price by March 31, 2025 compliance deadline.
Nasdaq Determination Letter (April 1) adds bid-price deficiency as additional delisting basis.
Deficiency will be considered at April 15 hearing alongside existing MVLS shortfall.
Company intends to seek extension from Nasdaq Hearings Panel; no assurance of success.
Tickers XAGE (common) and XAGEW (warrants) at risk of delisting from Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.